Advancing pediatric medical device development via non-dilutive NIH SBIR/STTR grant funding.
Advancing pediatric medical device development via non-dilutive NIH SBIR/STTR grant funding.
复制标题
DOI:
10.1016/j.jpedsurg.2021.01.025
复制
发表时间:
2021-11
影响因子:
2.4
通讯作者:
Koh CJ
中科院分区:
文献类型:
--
作者:
Sun RC;Kamat I;Byju AG;Wettergreen M;Heffernan MJ;Willson R;Haridas B;Koh CJ
A shortage of medical devices designed for children persists due to the smaller pediatric population and market factors. Furthermore, pediatric device development is challenging due to the limited available funding sources. We describe our experience with pediatric device projects that successfully received federal grant support towards commercializing the devices that can serve as a guide for future innovators. The developmental pathways of pediatric device projects at a tertiary-care children’s hospital that received NIH SBIR/STTR funding between 2016–2019 were reviewed. The clinical problems, designs, specific aims, and development phase were delineated. Pediatric faculty successfully secured NIH SBIR/STTR funding for five pediatric devices via qualified small business concerns (SBC’s). Three projects were initiated in the capstone engineering design programs and developed further at two affiliated engineering schools, while the other two projects were developed in the faculty members’ labs. Four projects received funding via established SBC’s, while one was awarded funding via a newly established SBC. NIH SBIR/STTR grants are an essential source of external non-dilutive funding for pediatric device innovation and especially for academic-initiated projects. This funding can provide needed early-stage support to facilitate commercialization. In addition, these grants can serve as achievable accomplishments for pediatric faculty portfolios toward academic promotion. Our experience shows that it is possible to build a robust innovation ecosystem comprised of academic faculty (clinical/engineering) collaborating with local device development companies while jointly implementing a product development strategy leveraging NIH SBIR/STTR funding for critical translational research phases of pediatric device development.
登录
查看更多内容
影响因子:
8
作者:
Ulrich, Linda C.;Joseph, Francesca D.;Koenig, Robert L.
通讯作者:
Koenig, Robert L.
影响因子:
2.4
作者:
Sack BS;Elizondo RA;Huang GO;Janzen N;Espinoza J;Sanz-Cortes M;Dietrich JE;Hakim J;Richardson ES;Oden M;Hanks J;Haridas B;Hury JF;Koh CJ
通讯作者:
Koh CJ
影响因子:
0.9
作者:
Peiris, Vasum;Xu, Kui;Lewis, Debra Y.
通讯作者:
Lewis, Debra Y.
影响因子:
8
作者:
Hwang, Thomas J.;Kesselheim, Aaron S.;Bourgeois, Florence T.
通讯作者:
Bourgeois, Florence T.
影响因子:
0.8
作者:
Grant, Matthew;Stanasel, Irina;Koh, Chester J
通讯作者:
Koh, Chester J